yocarditis is an inflammation of the myocardium, which often follows microbial infections (1). Two variants of Coxsackievirus B3 (CVB3) 3 have been used to study myocarditis in BALB/c mice. One variant, designated H3, causes severe cardiac inflammation and high animal mortality (2). The second variant, designated H310A1, differs from the H3 virus by a single amino acid mutation in the VP2 capsid protein and induces minimal myocarditis and mortality (3, 4). Why this single amino acid difference between H3 and H310A1 viruses should have such a strong biological effect on disease susceptibility is not clearly understood, but may partially depend upon differences in activation of innate immunity represented by proinflammatory cytokines and ␥␦ ϩ T cells. H3 infection of cultured monocytes induces strong TNF-␣ secretion which is not observed with H310A1 (5). TNF-␣ is necessary for CVB3 pathogenicity (6 -8). A second difference between H3 and H310A1 virus infections is that only the former virus activates V␥4 ϩ T cells, which promote myocarditis susceptibility (9). ␥␦ ϩ cells comprise up to 50% of the T cell infiltrate in the hearts of H3-infected animals (8, 10). As with ␣␤ TCR ϩ cells, ␥␦ ϩ T cells can be distinguished by their variable (V) gene usage. V␥1
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ϩ T cells induce myocarditis resistance while V␥4 ϩ T cells induce susceptibility (9, 11) . In the present studies, we show that H3 virus infections up-regulate expression of CD1d (a nonpolymorphic MHC I-like molecule often associated with innate immunity and control of infectious agents (12) (13) (14) (15) (16) (17) (18) both in vitro on infected myocytes and in vivo in the heart. V␥4 ϩ cells isolated from H3 virus-infected BALB/c mice kill H3 virus-infected myocytes by recognition of CD1d in vitro. Since the classical invariant NKT (J␣281 ϩ ) cells are not involved in CVB3-induced myocarditis and since V␥4 ϩ cells have already been shown to determine myocarditis susceptibility, we hypothesize that the requirement for CD1d in this disease is probably functioning at the level of the V␥4 ϩ cells.
Materials and Methods

Mice
Male BALB/cJ, BALB/c-CD1d KO (CD1d Ϫ/Ϫ ), and BALB/c J␣281 Ϫ/Ϫ mice, 6 -8 wk of age, were used in these experiments. BALB/cJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Breeding pairs of BALB/c CD1d Ϫ/Ϫ mice were kindly supplied by Dr. M. Grusby (Harvard School of Public Health, Boston, MA); breeding pairs of BALB/c J␣281 Ϫ/Ϫ mice were kindly supplied by Dr. M. Taniguchi (Chiba University, Chiba, Japan, and currently RIKEN, Japan).
Virus, virus infection, and virus titration
Animals were infected by i.p. injection of 0.2 ml of PBS containing 10 4 PFU of CVB3 H3 or H310A1 variants as described previously (9) . Virus titers in tissues or in in vitro cell populations were determined by the plaque-forming assay as described earlier. Infectious center assay was used to determine the percentage of myocytes infected (19) .
Antibodies
Ab class control (isotype control) and Ag-specific Abs were obtained from BD PharMingen (San Diego, CA). These included: PE-conjugated anti-CD3 (clone 17A2); purified rat anti-mouse CD16/CD32 (Fc Block; clone 2.4G2); CyChrome, FITC, and PE-rat IgG1 (clone R3-34); FITC-and PEconjugated anti-mouse IFN-␥ (clone XMG 1.2); PE-rat anti-mouse IL-4 (clone BVD4-1D11); PE-hamster anti-mouse CD69 (clone H1.2F3); CyChrome-rat anti-mouse CD4 (clone GK 1.5); purified, FITC, and PE-hamster IgG; purified and FITC anti-mouse CD1d (clone 1B1); purified anti-mouse H-2D d (clone 34-2-12); purified anti-mouse H-2K d (clone SF1-1.1); purified anti-mouse IA/IE (clone 2G9); and FITC-anti-␦ TCR (clone GL3). FITC-conjugated mAbs to V␥1 (clone 2.11) and V␥4 (clone UC3) were prepared and tested in the laboratory of Dr. R. O'Brien (National Jewish Medical and Research Center, Denver CO). PE-streptavidin was purchased from BD PharMingen.
Isolation of splenic lymphocytes
Isolation of cell populations has been described previously (9) . Briefly, spleens were pressed through fine mesh screens, centrifuged on Histopaque-1077 (Sigma-Aldrich, St. Louis, MO), to remove RBC, and incubated on nylon wool for 30 min at 37°C. The nonadherent cells were retrieved. To isolate enriched V␥1 ϩ or V␥4 ϩ cells, splenocytes after nylon wool incubation were depleted of CD4 ϩ and MHC class II (IA/IE ϩ ) cells using anti-CD4 and anti-IA/IE Ab treatment of the cells followed by incubation with anti-rat IgG-conjugated magnetic particles. The remaining cells were divided into three different tubes and incubated in 500 l of PBS-1% BSA containing a 1/50 dilution of either FITC anti-V␥4 and PE anti-CD3 (tube 1) or anti-V␥1 and PE-anti-CD3 (tube 2) for 20 min on ice, washed, and resuspended in RPMI 1640 containing 10% FBS (Life Technologies, Grand Island, NY) and sterile sorted.
Isolation of neonatal myocytes
Isolation of neonatal mouse myocytes has been described previously (20) . Briefly, hearts are obtained from mice within 72 h of birth, minced finely, and subjected to sequential digestion with 0.25% pancreatin (Life Technologies) and 0.4% collagenase (Worthington Biochemical, Freehold, NJ). The single-cell suspension was washed and depleted of endothelial cells and fibroblasts by two sequential 1-h adsorptions to plastic. The nonadherent population was retrieved and plated into 1-mm tissue culture wells (Falcon Plastics, Oxnard, CA) at 1 ϫ 10 3 cells/well. After 48 h at 37°C in a humidified 5% CO 2 incubator, the wells were used for cytotoxicity assays.
Confocal microscopy
BALB/c and CD1d
Ϫ/Ϫ mice were uninfected or were infected i.p. with H3 or H310A1 virus and then killed 3 days later. Hearts were perfused with PBS, snap frozen in Tissue Freezing Medium (TBS; Triangle Biological Sciences, Durham, NC) in liquid nitrogen, then sectioned using a TBS cryostat into 10-m sections and placed on glass slides (Fisher Superfrost Plus; Fischer Scientific, Pittsburgh, PA). Tissue was fixed for 10 min in Ϫ20°C acetone, rehydrated in PBS containing 1% BSA for 20 min, incubated for 30 min in PBS-BSA containing 1% normal goat serum, and then incubated for 1 h in PBS-BSA containing a mixture of 1/100 dilutions of mouse anti-CVB3 (IgM, clone 8A6; Ref. 21) , anti-CD1d (rat IgG, clone 1B1; BD PharMingen) and anti-muscle ␣-actin (mouse IgG, clone 5F8; InnoGenex, San Ramon, CA). The tissues were washed and incubated with PBS-BSA containing a mixture of 1/100 dilutions of Cy5-anti-mouse IgM (Jackson ImmunoResearch, West Grove, PA), Alexa 568 anti-mouse IgG and Alexa 488 anti-rat IgG (Molecular Probes, Eugene OR) for 1 h, washed three times, and evaluated using a Bio-Rad MRC 1000 confocal scanning laser system (Hercules, CA) mounted to an Olympus BX 50 microscope (Melville, NY) using an iris setting of 2.0.
Cell-mediated cytotoxicity assay
The cell-mediated cytotoxicity assay has been described in detail previously (20) . Infected targets were incubated with 100 multiplicity of infection virus for 1 h, washed, and incubated with fresh medium for 12 h. Targets were labeled with 100 Ci of 51 Cr (Na 2 51 CrO 4 ; ICN Pharmaceuticals, Irvine, CA) for 2 h at 37°C, washed four times, and cultured for 12 h at 37°C with 1 ϫ 10 4 lymphocytes (E:T ratio, 10:1). Supernatants were removed and counted in a Packard Gamma Counter (Packard Instrument; Downers Grove, IL). Pellets were lysed using 6 N HCl and the pellets were removed and counted. Percent 51 Cr release was calculated as: cpm in supernatant/(cpm in supernatant ϩcpm in pellet) ϫ 100 for each well. Percent specific lysis represents: (percent 51 Cr release in experimental wells) Ϫ (percent 51 Cr in wells without lymphocytes; medium control wells). In some experiments, soluble recombinant Fas-Fc (10 g/ml; R&D Systems, Minneapolis, MN) or concanamycin A (CMA, 100 nM; SigmaAldrich) was added to the assay wells.
Flow cytometry
Myocytes were labeled with 1/100 dilutions of FITC anti-V␥1 or FITCanti-V␥4 Ab for 20 min at 4°C. The cells were washed in PBS-1% BSA and fixed for 10 min in 2% paraformaldehyde, then incubated with a 1/100 dilution mouse anti-␣-actin, followed by incubation with a 1/100 dilution of PE-anti-mouse IgG. For labeling of cell surface markers (CD3, CD4, V␥1, V␥4, CD69), cells were incubated in PBS-1% BSA containing a 1/100 dilution of the relevant fluorochrome-labeled Abs and a 1/100 dilution of Fc-Block for 20 min at 4°C, washed twice with PBS-BSA, and resuspended in 2% paraformaldehyde. For intracellular cytokine staining, cells were cultured in medium containing 10 g/ml brefeldin A, 50 ng/ml PMA, and 500 ng/ml ionomycin (Sigma-Aldrich) for 4 h at 37°C in 5% CO 2 . The cells were washed once in PBS-BSA containing brefeldin A and resuspended in PBS-BSA-brefeldin A containing a 1/100 dilution of CD4 for 20 min at 4°C, washed, and fixed in 2% paraformaldehyde for 10 min. The cells were washed once in PBS-BSA buffer containing 0.05% saponin and resuspended in PBS-BSA-saponin containing 1/100 dilutions of Fc Block, FITC-anti-IFN-␥, and PE-anti-IL-4 Abs and 50 g/ml rat polyclonal IgG (Zymed Laboratories, San Francisco, CA). After incubation for 30 min, the cells were washed twice in PBS-BSA-saponin, then once in saponin-free PBS-BSA to close the membrane, and resuspended in PBS containing 2% paraformaldehyde. Positive controls for cytokine staining were 2.5 ϫ 10 5 of either MIC-1 (IFN-␥) and MIC-2 (IL-4) fixed cells obtained from BD PharMingen. Negative controls were fluorochrome-conjugated species-and isotype-matched Ig combinations as used in specific Ab-staining samples. Stained cell populations were analyzed using a Coulter Epics Elite instrument with a single excitation wavelength (488 nm) and band filters for PE (575 nm), FITC (525 nm), Red613 (613 nm), and CyChrome (670 nm). Each sample population was classified for cell size (forward scatter) and complexity (side scatter), then gated on a population of interest. At least 10,000 cells were evaluated for each sample. Criteria for positive staining were established using isotype controls. The results are expressed as the percentage of total splenocytes staining for a particular marker minus the isotype control.
Histology
Hearts were removed, fixed in 10% buffered Formalin, paraffin embedded, sectioned, and stained with H&E. Stained sections were evaluated for myocarditis as described previously (9) .
Statistics
Statistical evaluation was performed using the Wilcoxon ranked score method. Each experiment was repeated at least two times.
Results
Myocarditis in BALB/c, BALB/c CD1d
Ϫ/Ϫ , and BALB/cJ␣281 Ϫ/Ϫ mice Male mice were infected with H3 virus and surviving animals were euthanized 7 days later. Cumulative mortality was 67% (10/15) for wild-type, 50% (5/10) for J␣281 Ϫ/Ϫ , and 25% (2/8) for CD1d Ϫ/Ϫ mice. No significant difference was observed between the strains in cardiac virus titers (Table I) ; however, myocarditis was significantly reduced in CD1d Ϫ/Ϫ animals (0.5% of the myocardium inflamed compared with 9.3% for BALB/c mice). CD1d Ϫ/Ϫ mice also had decreased numbers of CD4 ϩ IFN-␥ ϩ , but greater numbers of CD4 ϩ IL-4 ϩ cells in the spleen (Table I) . 
a BALB/c and transgenic BALB/c male mice 6 -8 weeks of age were infected with 10 4 PFU of H3 virus and euthanized 7 days later. Hearts were removed and evaluated for the percentage of myocardium inflamed and for virus titer. Spleens were removed, centrifuged on Histopaque, and the lymphoid population was surface stained with CyChrome anti-mouse CD4 and intracellularly stained for FITC-anti IFN␥ and PE-anti IL-4. For evaluation of ␥␦ ϩ cell populations, spleen cells were stained with FITC-anti-␥␦ (GL3), PE-anti-CD69, and either biotynlated anti-V␥1 (clone 2.11) or V␥4 (clone UC3) and CyChrome-streptavidin. Results represent mean Ϯ SEM of three to five mice per group.
b Significantly different from BALB/c at p Յ 0.05.
in the CD1d Ϫ/Ϫ mouse. We have previously shown that V␥4 ϩ cells promote myocarditis susceptibility (9 ϩ NKT cell as well as wild-type mice are susceptible to myocarditis.
CD1d expression in vivo and in vitro during H3 and H310A1 virus infections
Since H3 only induces myocarditis in CD1d ϩ mice, the next studies investigated whether CD1d expression alters in vivo and in vitro during H3 and H310A1 infection. In initial studies, neonatal cardiac myocytes were isolated, infected with 100 PFU of virus/ cell for 18 h, then labeled with PE-anti-␣-actin and FITC antiCD1d. After gating on the ␣-actin-positive population, the percentage of myocytes positive for CD1d was determined (Fig. 1) . Approximately 37.2% of H3 virus-infected BALB/c myocytes expressed CD1d compared with Ͻ2% of either uninfected or H310A1 virus-infected cells. To confirm specificity of the CD1d labeling, myocytes were isolated from CD1d Ϫ/Ϫ mice and infected with H3 virus. None of these myocytes were labeled with antiCD1d Ab above the isotype control level.
To confirm similar virus infectivity as myocytes, replicate cultures were infected with virus for 18 h, the cells were retrieved by incubation in EDTA and manual scraping, counted, and frozen and thawed three times. The supernatant from four replicate wells for each group was tittered for virus. Titers (per 10 4 myocytes) were 0 PFU for uninfected BALB/c, 2.4 Ϯ 0.7 ϫ 10 5 PFU for H3-infected BALB/c, 3.1 Ϯ 0.4 ϫ 10 5 PFU for H3-infected CD1d Ϫ/Ϫ , and 1.9 Ϯ 0.6 ϫ 10 5 PFU for H310A1 virus-infected BALB/c myocytes. There was no significant difference in virus titers between any of the infected myocyte groups. Infectious center assays were performed to determine the percentage of infected myocytes. Results indicate that 48 Ϯ 12% of BALB/c myocytes were infected with H3, 39 Ϯ 8% BALB/c myocytes were infected with H310A1, and 55 Ϯ 18% of CD1d Ϫ/Ϫ myocytes were infected with H3 virus in four replicate wells for each group (no significant difference). These studies were repeated three times with similar results in each experiment.
Next, BALB/c and CD1d Ϫ/Ϫ mice were infected with either H3 or H310A1 virus. On day 3 after infection, the hearts were perfused with PBS, snap frozen, and sectioned for confocal microscopy (Fig. 2) . The myocardium was visualized using anti-␣-actin and Cy3-conjugated anti-mouse IgG Ab (red, stains myocardial cells). Virus-infected cells were identified using monoclonal anti-CVB3 Ab (mouse IgM) and Cy5-anti-mouse IgM (-chain specific; blue). CD1d expression was determined using anti-CD1d (rat IgG) and Alexa 488 anti-rat IgG Ab (green). Uninfected BALB/c mice showed actin staining but neither virus nor CD1d. Both H3-infected CD1d
Ϫ/Ϫ and H310A1-infected BALB/c hearts showed infected myocytes (purple due to colocalization of blue and red), but no significant CD1d expression. In contrast, hearts from H3-infected BALB/c mice showed substantial numbers of CD1d ϩ cells. Although CD1d is associated with virus-positive cells, other CD1d ϩ cells are not myocytes and do not appear to be infected. These may represent CD1d ϩ inflammatory cells rapidly infiltrating the heart during H3 virus infection. Double-color analysis of CD1d (green) and virus (blue) provides better visualization of virus-positive and virus-negative CD1d ϩ cells without the complication of ␣-actin staining (Fig. 3) . Analysis of hearts at a later time (day 6 after infection) showed more widespread CD1d ϩ cells in H3-infected BALB/c mice but few virus-positive cells. Again, few CD1d ϩ cells were seen in H310A1-infected BALB/c hearts at this time (data not shown).
Lysis of H3-infected myocytes by V␥4
ϩ cells
The following studies investigated whether V␥1 ϩ or V␥4 ϩ effector cell populations could directly kill infected myocyte targets in vivo. V␥1 ϩ and V␥4 ϩ effector cell populations were isolated from uninfected BALB/c mice or from BALB/c or CD1d
Ϫ/Ϫ mice infected 7 days earlier with either H3 or H310A1 virus. Fig. 4 shows representative purity of the sorted effector cell populations. Effectors were assayed on 51 Cr-labeled H3 virus-infected myocyte targets. Fig. 5A shows that only V␥4 ϩ cells from H3-infected BALB/c mice showed cytotoxicity to the infected targets. Neither V␥1 ϩ cells isolated from H3-infected BALB/c mice nor V␥4 ϩ cells from uninfected BALB/c mice were cytolytic. This indicates that not all ␥␦ ϩ cell subpopulations from H3 virus-infected mice kill cardiac myocytes and that virus infection of V␥4 ϩ cell donors is required to activate cytotoxic potential. In a second set of experiments, V␥4 ϩ cells were isolated from H3-infected BALB/c donors and assayed for cytotoxicity against BALB/c (uninfected, H3, or H310A1 infected) and CD1d Ϫ/Ϫ (H3 infected) myocyte targets (Fig. 5B) . The V␥4 ϩ effectors were cytolytic to the H3-infected BALB/c (CD1d ϩ ) but not to CD1d Ϫ/Ϫ myocytes. Also, no cytotoxicity was observed to either uninfected or H310A1 virus-infected BALB/c myocytes. One possibility is that V␥4 ϩ cells from H3-infected mice do not kill H310A1 virus-infected targets due to viral specificity of the V␥4 ϩ cell populations. In Fig. 5C , V␥4 ϩ cells were isolated from H310A1-infected BALB/c mice and assayed for cytotoxicity to both H3 and H310A1 virus-infected myocytes. The V␥4 ϩ cells from H310A1 virus-infected donors were not significantly lytic to either infected target. Thus, not only do the effectors need to come from H3-infected donors, but these cells can distinguish between uninfected and H3-infected targets.
Since H3 infection increases CD1d expression on myocytes, V␥4 ϩ cells may need this molecule for myocyte killing. To investigate this possibility, V␥4 ϩ cells from H3 virus-infected BALB/c donors were assayed for cytotoxicity on H3 virus-infected myocytes in the presence or absence of mAbs (1 g/ml) to CD1d, MHC class I K d or D d Ags, or MHC class II IA/IE Ag to the cultures (Fig. 6) . Only the anti-CD1d blocked cytotoxicity.
Finally, studies were done to determine whether V␥4 ϩ cells kill myocyte targets through Fas-dependent or perforin-dependent mechanisms (Fig. 7) . V␥4 ϩ cells were isolated from H3-infected BALB/c donors and assayed on H3 virus-infected BALB/c myocyte targets in medium containing either CMA to block perforindependent killing or Fas-Fc to block Fas-dependent killing. Only the Fas-Fc inhibited V␥4 ϩ cell-mediated cytotoxicity.
Discussion
These studies show the following major points: 1) CD1d is important in myocarditis susceptibility during H3 virus infection; 2) CD1d expression is increased in H3-infected neonatal myocytes in vitro and in the myocardium in vivo; 3) H310A1, differing from the H3 variant by a single amino acid mutation in the VP2 capsid protein (4), does not increase CD1d expression on neonatal myocytes in vitro or in the heart in vivo; and 4) V␥4 ϩ cells kill CD1d ϩ but not CD1d Ϫ/Ϫ -infected myocytes in vitro. MHC class I-like CD1 molecules are involved in innate immunity to many infectious agents (12) (13) (14) (15) (22) (23) (24) (25) . Most often, CD1d-restricted cells belong to the invariant NKT subpopulation (12-15, 22, 24, 26) , although T cells expressing noninvariant TCR have also been reported to be CD1 restricted (26 -28) . Finding a CD1d-restricted murine CTL belonging to the ␥␦ ϩ T cell population extends current knowledge regarding these diverse types of CD1d-restricted immune responses in the mouse (29, 30) . CD1d-restricted T cells can make either Th1 (IFN-␥) or Th2 (IL-5, IL-4) cytokines, depending upon the model system used (14, 26, 30, 31) . Although cytokine bias of the CD1d-restricted effector might reflect an inherent characteristic of the T cell, CD1d is expressed on dendritic and other APCs, and the APC may be the determining factor in T cell cytokine bias (23, 32, 33) . Our studies in CVB3-induced myocarditis resemble those in hepatitis C virus-infected humans (30) , in which CD1-restricted intrahepatic lymphocytes were increased in patients with chronic hepatitis C infections, but cells expressing the invariant TCR were rare. The CD1d-restricted intrahepatic lymphocytes were strongly Th1 biased and cytolytic. Despite TCR utilization by NKT cells for CD1d recognition, it is not certain whether CD1d recognition by V␥4 ϩ T cells is through the TCR. This point will need further investigation.
Generally, CD1 molecules bind hydrophobic lipids or peptides (17) . In bacterial infections, the lipid Ags can derive from the bacterial membrane. This cannot be true of CVB3 because these are nonenveloped viruses. However, CVB3-infected cells might release glycolipid Ags, which could be exogenously taken up by target CD1d ϩ cells, or glycolipids endogenous to the CD1d ϩ cell might provide the relevant Ag. A hydrophobic virus peptide is also a possible candidate for the CD1d-restricted Ag. A large number of CD1d ϩ cells rapidly appear in the hearts of H3-infected BALB/c mice. The nature of these cells in not known, but presumably represent various lymphoid cells infiltrating the heart and may even be the ␥␦ ϩ cells themselves (16, 34) . V␥4 ϩ effectors could directly induce cardiac injury since these cells are cytolytic to infected myocytes in vitro. It is not clear how ϩ and V␥4 ϩ cell populations were isolated from uninfected, H3-, or H310A1-infected BALB/c mice and from H3-infected CD1 Ϫ/Ϫ mice 7 days after infection as described in Materials and Methods. Neonatal cardiac myocytes were isolated from 3-day-old BALB/c mice infected with H3 virus at 100 PFU/cell for 12 h, then incubated with the effector cells at an E:T ratio of 10:1 and incubation time of 6 h. B, Neonatal cardiac myocytes were isolated from 3-day-old BALB/c or CD1
Ϫ/Ϫ mice. Cells were either uninfected or infected with 100 PFU/cell H3 or H310A1 virus for 12 h, then incubated with V␥4 ϩ cells obtained from H3-infected BALB/c mice 7 days after infection. C, Neonatal BALB/c cardiac myocytes were uninfected or infected with either H3 or H310A1 virus, then incubated with V␥4 ϩ cells isolated from H310A1 virus-infected BALB/c mice 7 days after infection. Results represent the mean percent lysis of four or more mice per group Ϯ SEM in one of two replicate experiments. much of the total myocyte destruction results from the V␥4 ϩ effector. Certainly, ␥␦ ϩ cells comprise a large proportion of the inflammatory cells in myocarditis (8) . We have shown that up to 50% of the lymphoid cells recoverable at the time of peak myocarditis are ␥␦ ϩ TCR ϩ and that these effectors are strongly positive for Fas ligand expression. However, maximum Coxsackievirus replication is observed between 3 and 4 days after infection and the infectious virus is rapidly cleared by day 10 (35). Since V␥4 ϩ cells kill infected but not uninfected myocytes in vitro, presumably damage mediated by this effector should be limited to periods of virus infection. If persistent virus infections are established, as has been reported by some investigators in CVB3-induced heart disease (36) , the amount of cytotoxicity may be significant. V␥4 ϩ cells kill CD1d ϩ H3-infected neonatal myocytes in vitro. It is not known whether they can also kill adult myocytes. Unfortunately, isolation of viable adult myocytes is extremely difficult, if not impossible. Although we infer that V␥4 ϩ cells also kill adult cells of the same type, this may not be true. An alternative hypothesis is that V␥4
ϩ cells affect myocarditis susceptibility in more than one way. As reported earlier and as shown in Table I , myocarditis susceptibility correlates to preferential activation of CD4 ϩ Th1 (IFN␥ ϩ ) cell responses (9) . Both NKT and ␥␦ ϩ cells are known to produce pro-and anti-inflammatory cytokines as part of the innate immune response and influence developing adaptive immunity (14, 30, 37, 38) . The V␥4 ϩ cells in H3 virus-infected BALB/c mice are strongly IFN-␥ ϩ and production of this cytokine is important for their ability to bias CD4 ϩ T cell responses toward a Th1 phenotype (9) . It is presently not known whether V␥4 ϩ cells induced in CD1d ϩ mice and apparently recognizing CD1d Ag are primarily pathogenic through their direct ability to kill infected cells or through their ability to modulate adaptive immunity through production of IFN-␥ early in the infection.
The cytolytic V␥4 ϩ cell population is primarily (Ͼ80%) CD4 Ϫ CD8 ϩ . The V␥1 ϩ cell population is primarily CD4 Ϫ CD8 Ϫ (Ͼ95%). However, in both populations, a minority of other phenotype cells are present (ϳ20% CD4 Ϫ CD8 Ϫ V␥4 ϩ cells and ϳ5% CD4 Ϫ CD8 ϩ V␥1 ϩ cells). No CD4 expression was noted in either sorted cell population. It is not known what proportion of the total V␥4 ϩ cells isolated from H3-infected BALB/c mice actually modulate myocarditis. This is likely to be a heterogeneous population with regard to V␦ gene usage and only a specific V␥4 ϩ V␦ population might prove pathogenic. Positive selection of NKT cells during ontogeny involves CD1d (39, 40) , like conventional T cell MHC restriction (41, 42) . Although V␥4 ϩ cells are found in CD1 Ϫ/Ϫ mice, it is possible that the specific CD1d-reactive V␥4 ϩ subpopulation may be absent rather than not activated. A remaining question is why the single amino acid mutation between the H3 and H310A1 viruses had such a dramatic effect on CD1d expression in vitro and in vivo in the heart. Some reports find that multiple cytokines can up regulate CD1d expression on various tumor cell lines including IFN-␥, IL-4, IL-10, and GM-CSF (31) . Other investigators find constitutive expression of CD1d without marked enhancement by these cytokines (34, 43, 44) , although activation of T cells can up-regulate CD1d expression through unknown mechanisms (45) . Since infections with H3 virus induce high expression of at least certain cytokines (TNF-␣; Ref. 5) , it is possible that one or more of these factors could increase CD1d expression.
